Ansell Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Ansell Stock Forecast and Price Target
If Ansell's stock price reached the average yearlong target of $17.68 given by well-known analysts in recent months, there would be a potential downside of approximately -28.74% from its last closing price in April, 2024. This potential increase is based on a high estimate of $21.18 and a low estimate of $14.99. You may be interested in rivals even if you aren't interested in Ansell stock.
-28.74% Downside
Ansell Fair Value Forecast for 2023 - 2025 - 2030
Ansell's Price has decreased In the last four years, from $29.57 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $22.06 – an increase of 100.00%. For the next seven years, experts predict that Ansell's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PG Stock Forecast | Procter & Gamble | Outperform |
12
|
$157.29 | Buy/Sell | $166.80 | 9.63% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$145.74 | Buy/Sell | $174.55 | 16.65% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.39 | Buy/Sell | $32.87 | 20.13% |
| HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$191.08 | Buy/Sell | $219.12 | 16.44% |
| ULVR Stock Forecast | Unilever PLC | Hold |
8
|
£37.70 | Buy/Sell | £50.61 | 31.72% |
Ansell Revenue Forecast for 2023 - 2025 - 2030
Ansell's Revenue has grown In the last three years, rising from $1.61B to $1.66B – a growth of 2.57%. In the next year, analysts believe that Revenue will reach $1.67B – an increase of 0.84%. For the next seven years, experts predict that Ansell's Revenue will grow at a rate of 10.78%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SAN Stock Forecast | Sanofi | Outperform |
16
|
85.23€ | Buy/Sell | 102.80€ | 26.72% |
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$86.71 | Buy/Sell | $88.97 | 7.25% |
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£41.39 | Buy/Sell | £66.68 | 38.92% |
.jpg)
Ansell Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Ansell's Dividend per Share has seen a drop from $0.50 to $0.46 – a 8.00% decrease. According to 11 major analysts, Ansell's Dividend per Share will fall by 13.04% in the next year, reaching $0.40. For the next seven years, the forecast is for Dividend per Share to grow by 20.22%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DD Stock Forecast | DuPont de Nemours | Outperform |
17
|
$73.53 | Buy/Sell | $75.38 | 8.80% |
| HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
16
|
71.90€ | Buy/Sell | 71.63€ | 4.31% |
| BAYN Stock Forecast | Bayer | Hold |
5
|
26.24€ | Buy/Sell | 45.15€ | 21.95% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CLX Stock Forecast | Clorox Co-The | Hold |
16
|
$143.20 | Buy/Sell | $154.18 | 8.24% |
| SHL Stock Forecast | Sonic Healthcare | Hold |
18
|
$25.91 | Buy/Sell | $34.12 | 19.64% |
| RHC Stock Forecast | Ramsay Health Care | Hold |
18
|
$50.58 | Buy/Sell | $56.32 | 10.74% |
Ansell EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Ansell's EBITDA has grown, moving from $252.10M to $254.20M – an increase of 0.83%. In the next year, analysts predict that EBITDA will jump to $258.17M – up 1.56% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 25.97%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HARTA Stock Forecast | Hartalega Holdings Berhad | Hold |
18
|
RM2.69 | Buy/Sell | RM2.37 | -5.20% |
| TOPGLOV Stock Forecast | Top Glove Corporation Bhd. | Underperform |
15
|
RM0.83 | Buy/Sell | RM0.68 | 1.20% |
| EVT Stock Forecast | EVT | Outperform |
10
|
$12.03 | Buy/Sell | $14.00 | 2.24% |
Ansell EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Ansell's EBIT has decreased from $219.70M to $210.50M – a 4.19% drop. In the following year, 11 experts forecast that Ansell's EBIT will decrease by 11.97%, to $185.30M. Over the next seven years, experts predict that Ansell's EBIT will grow at a rate of 14.59%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PHH2 Stock Forecast | Paul Hartmann | - |
18
|
198.00€ | Buy/Sell | 0.00€ | -100.00% |
| SIG Stock Forecast | Sigma Healthcare | Hold |
12
|
$1.28 | Buy/Sell | $0.83 | -7.81% |
| KOSSAN Stock Forecast | Kossan Rubber Industries Bhd | Hold |
18
|
RM2.15 | Buy/Sell | RM1.39 | -12.56% |
Ansell EPS Price Prediction Forecast for 2023 - 2025 - 2030
Ansell's EPS has decreased In the last four years, from $1.22 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $0.91 – an increase of 100.00%. For the next seven years, experts predict that Ansell's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| STGT Stock Forecast | Sri Trang Gloves (Thailand) Pu... | Sell |
18
|
฿8.40 | Buy/Sell | ฿10.20 | 48.81% |
| CUV Stock Forecast | Clinuvel Pharmaceuticals | Buy |
16
|
$15.29 | Buy/Sell | $27.41 | 44.87% |
| SUPERMX Stock Forecast | Supermax Corporation Berhad | Hold |
16
|
RM0.82 | Buy/Sell | RM0.97 | 19.51% |
.jpg)